The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
ARO Q&A #2: Guidance application to standard reviews
-
Q: Do we need to adhere the standards of the new Guidance Document for Format Requirements and Submissions Processes if we are not using the AROs?
A: Yes, the guidance applies to all submissions as of July 4th to ensure consistency across all submissions.